Psilocybin for anxiety and depression in cancer care? Lessons from the past and prospects for the future.
J Psychopharmacol – December 01, 2016
Source: PubMed
Summary
Remarkably, historical insights reveal psilocybin's significant potential to alleviate anxiety and depression in cancer patients. Investigations into past clinical observations and modern trials suggest that a single dose can lead to rapid, sustained reductions in psychological distress. This therapeutic approach offers a promising avenue for improving mental well-being, providing profound relief and enhancing quality of life. The evidence points to a future where such interventions could become a vital part of supportive cancer care.
Abstract
Psilocybin for anxiety and depression in cancer care? Lessons from the past and prospects for the future.